Insights from 2023 ASCO® Annual Meeting
A

ASCO® 2023 Insights: "Myeloid for Measure - New Therapeutics in MDS and AML"

By Insights from 2023 ASCO® Annual Meeting FEATURING Anand Patel
By Insights from 2023 ASCO® Annual Meeting FEATURING Anand Patel
884 views
June 8, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Recommended

21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.4K views

·

8 months ago
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.2K views

·

9 months ago
19:01

Debates in AML: 7+3 Is No Longer the Standard of Care

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

598 views

·

2 months ago
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

705 views

·

4 months ago
17:51

Treatment of AML: Managing the Patient When Transplant Is Not an Opt…

Indy Hematology Review

H. Erba

882 views

·

7 months ago
19:21

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

494 views

·

4 months ago
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

729 views

·

7 months ago
27:26

Where I Use Azacitidine and Venetoclax in AML: Present and Future

SOHO Brazil 2024

J. Lancet

456 views

·

4 months ago
28:02

2024 Updates in AML

University of Colorado Division of Hematology

C. McMahon

733 views

·

7 months ago
14:32

Summary of Recent Updates in MDS

Vanderbilt University Medical Center (VUMC)

S. Ball

432 views

·

4 months ago
22:30

Emerging Treatment Options for AML in 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

A. Perl

697 views

·

8 months ago
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

883 views

·

7 months ago
09:51

MRD Testing in Leukemias: When Negativity Is a Positive Thing

i3 Health

N. S. Raje

465 views

·

8 months ago
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

395 views

·

5 months ago
48:04

Integrating Targeted Therapies in AML

Icahn School of Medicine at Mount Sinai

H. Kantarjian

410 views

·

5 months ago
14:39

Immunotherapies in Acute Leukemias: 2024 Update

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

C. Lai

503 views

·

8 months ago
14:58

ASCO® 2024 Summary: "Optimal Treatment Strategies for Younger Patien…

2024 ASCO® Annual Meeting Insights Hub

C. McMahon

288 views

·

5 months ago
19:10

SOHO Italy 2023: How I Treat AML at MD Anderson Cancer Center

5th SOHO Italy Annual Conference

H. Kantarjian

594 views

·

11 months ago
16:55

Making Sense of the New Classification Systems for MDS in 2024

Moffitt Cancer Center

R. Komrokji

444 views

·

8 months ago
27:28

AML: Current Treatment Landscape and Key Recent Updates

UChicago Medicine

A. Patel

382 views

·

8 months ago
AUTOPLAY